Los Angeles Capital Management LLC Invests $8.10 Million in Cardinal Health, Inc. $CAH

Los Angeles Capital Management LLC acquired a new stake in shares of Cardinal Health, Inc. (NYSE:CAH) during the second quarter, HoldingsChannel.com reports. The fund acquired 48,194 shares of the company’s stock, valued at approximately $8,097,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in CAH. MassMutual Private Wealth & Trust FSB boosted its position in Cardinal Health by 3.6% during the second quarter. MassMutual Private Wealth & Trust FSB now owns 1,767 shares of the company’s stock worth $297,000 after purchasing an additional 62 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management boosted its holdings in shares of Cardinal Health by 0.4% during the 2nd quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 17,805 shares of the company’s stock worth $2,991,000 after buying an additional 69 shares during the period. Perigon Wealth Management LLC boosted its holdings in shares of Cardinal Health by 3.2% during the 2nd quarter. Perigon Wealth Management LLC now owns 2,314 shares of the company’s stock worth $389,000 after buying an additional 72 shares during the period. Community Bank & Trust Waco Texas grew its stake in Cardinal Health by 1.3% in the 2nd quarter. Community Bank & Trust Waco Texas now owns 5,598 shares of the company’s stock valued at $940,000 after buying an additional 74 shares during the last quarter. Finally, Atlantic Edge Private Wealth Management LLC raised its holdings in Cardinal Health by 75.0% in the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock worth $29,000 after acquiring an additional 75 shares during the period. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Cardinal Health

In other news, insider Jessica L. Mayer sold 38,078 shares of Cardinal Health stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $5,666,767.96. Following the sale, the insider directly owned 48,457 shares in the company, valued at approximately $7,211,370.74. The trade was a 44.00% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Jason M. Hollar sold 107,705 shares of the company’s stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.90, for a total transaction of $16,037,274.50. Following the completion of the sale, the chief executive officer directly owned 235,901 shares in the company, valued at approximately $35,125,658.90. The trade was a 31.35% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 271,676 shares of company stock worth $40,489,525 in the last ninety days. Company insiders own 0.12% of the company’s stock.

Cardinal Health Trading Up 2.7%

Shares of CAH stock opened at $203.40 on Monday. Cardinal Health, Inc. has a 12 month low of $114.60 and a 12 month high of $203.67. The company has a market capitalization of $48.33 billion, a P/E ratio of 31.53, a P/E/G ratio of 1.39 and a beta of 0.72. The stock has a 50 day moving average of $160.02 and a two-hundred day moving average of $156.87.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.22 by $0.33. The business had revenue of $64.01 billion for the quarter, compared to analysts’ expectations of $59.41 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.Cardinal Health’s quarterly revenue was up 22.4% on a year-over-year basis. During the same period in the previous year, the business posted $1.88 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. Sell-side analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be paid a $0.5107 dividend. The ex-dividend date is Friday, January 2nd. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.0%. Cardinal Health’s dividend payout ratio is currently 30.77%.

Wall Street Analysts Forecast Growth

CAH has been the subject of a number of recent analyst reports. Leerink Partners upped their price target on shares of Cardinal Health from $187.00 to $211.00 in a report on Friday, October 31st. TD Cowen increased their target price on Cardinal Health from $183.00 to $225.00 and gave the company a “buy” rating in a research note on Monday, November 3rd. UBS Group raised their target price on Cardinal Health from $185.00 to $220.00 and gave the company a “buy” rating in a report on Friday, October 31st. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Cardinal Health in a research report on Wednesday, October 8th. Finally, Morgan Stanley reissued an “overweight” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Twelve research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, Cardinal Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $205.00.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.